425: Strive & Semler Scientific Announce Merger Plans

Strive, Inc. and Semler Scientific, Inc. are pursuing a business combination, with Strive reposting a communication on X.com regarding the proposed transaction.

Summary

• Strive, Inc. and Semler Scientific, Inc. are engaged in a proposed business combination.
• This communication, a Form 425 filing, was reposted on X.com by Ben Werkman, Chief Investment Officer of Strive, Inc., on October 24, 2025.
• The filing serves as a cautionary statement regarding forward-looking statements related to the proposed transaction, highlighting inherent risks and uncertainties.
• Strive intends to file a Registration Statement on Form S-4 with the SEC, which will include an Information Statement/Proxy Statement/Prospectus.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval of the proposed transaction.

Sentiment

Score: 5

Explanation: The filing is a standard legal disclosure (Form 425) related to a proposed business combination, primarily outlining forward-looking statements and associated risks. Its tone is neutral and factual, as expected for regulatory compliance.

Positives

• The proposed transaction is expected to yield strategic benefits for the combined company.
• Anticipated financial benefits are expected, including a positive impact on the combined company's future financial performance.
• Anticipated cost savings are expected from the proposed transaction.

Negatives

• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions from Strive's or Semler Scientific's customers.
• Potential changes to business or employee relationships resulting from the announcement or completion of the proposed transaction.

Risks

• The occurrence of any event, change, or other circumstances that could give rise to the right of one or both companies to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because conditions to closing are not received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• The possibility that anticipated benefits of the proposed transaction, including cost savings and strategic gains, are not realized when expected or at all.
• Risks associated with changes in, or problems arising from, implementation of Bitcoin treasury strategies and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement.
• The possibility that the integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated, including as a result of unexpected factors or events.
• Diversion of management's attention from ongoing business operations and opportunities.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other factors, including unknown or unpredictable factors, could harm Strive, Semler Scientific, or the combined company's results.

Future Outlook

Strive and Semler Scientific anticipate strategic and financial benefits from the proposed transaction, including a positive impact on the combined company's future financial performance and successful integration of businesses. The closing of the transaction is also expected.

Management Comments

• Ben Werkman, Chief Investment Officer of Strive, Inc., reposted the communication on X.com on October 24, 2025, in connection with Strive's proposed business combination with Semler Scientific, Inc.

Industry Context

The filing highlights risks associated with 'Bitcoin treasury strategies and other digital assets,' indicating a growing trend among companies, including those involved in mergers, to integrate digital assets into their financial strategies. This also suggests the evolving regulatory landscape and market volatility associated with such assets are key considerations in corporate transactions.

Stakeholder Impact

• Shareholders of Strive will experience dilution due to the issuance of additional Class A common stock.
• Customers of both Strive and Semler Scientific may have adverse reactions to the proposed transaction.
• Business and employee relationships at both companies could change as a result of the announcement or completion of the merger.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC to register the Class A common stock to be issued.
• The Registration Statement will include an Information Statement/Proxy Statement/Prospectus.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders.
• Semler Scientific stockholders will be asked to approve the proposed transaction.

Key Dates

Keywords

Strive Inc., Semler Scientific Inc., Merger, Business Combination, SEC Filing, Form 425, Bitcoin Treasury, Digital Assets, Corporate Governance, Risk Management